Pharma: Other News To Note
Monday, July 30, 2012
Mylan Inc., of Pittsburgh, reported that its subsidiary Mylan Pharmaceuticals Inc. received FDA approval for its generic version of Janssen Pharmaceutical Inc.'s Sporanox (itraconazole), indicated for the treatment of fungal infections that begin in the lungs in patients who are intolerant of or refractory to amphotericin B therapy.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.